150 related articles for article (PubMed ID: 19066323)
1. Body mass index and serum lipid changes during treatment with valproic acid in children with epilepsy.
Grosso S; Mostardini R; Piccini B; Balestri P
Ann Pharmacother; 2009 Jan; 43(1):45-50. PubMed ID: 19066323
[TBL] [Abstract][Full Text] [Related]
2. Lack of valproic acid-associated weight gain in prepubertal children.
Espinosa PS; Salazar JC; Yu L; Mendiondo MS; Robertson WC; Baumann RJ
Pediatr Neurol; 2008 Sep; 39(3):177-80. PubMed ID: 18725062
[TBL] [Abstract][Full Text] [Related]
3. The role of ghrelin in weight gain and growth in epileptic children using valproate.
Gungor S; Yücel G; Akinci A; Tabel Y; Ozerol IH; Yologlu S
J Child Neurol; 2007 Dec; 22(12):1384-8. PubMed ID: 18174556
[TBL] [Abstract][Full Text] [Related]
4. Metabolic alterations during valproic acid treatment: a prospective study.
Abaci A; Saygi M; Yis U; Demir K; Dirik E; Bober E
Pediatr Neurol; 2009 Dec; 41(6):435-9. PubMed ID: 19931165
[TBL] [Abstract][Full Text] [Related]
5. Ghrelin levels are reduced in prepubertal epileptic children under treatment with carbamazepine or valproic acid.
Prodam F; Bellone S; Casara G; De Rienzo F; Grassino EC; Bonsignori I; Demarchi I; Rapa A; Radetti G; Bona G
Epilepsia; 2010 Feb; 51(2):312-5. PubMed ID: 19780793
[TBL] [Abstract][Full Text] [Related]
6. Serum lipids, vitamin B12 and folic acid levels in children receiving long-term valproate therapy.
Geda G; Caksen H; Içağasioğlu D
Acta Neurol Belg; 2002 Sep; 102(3):122-6. PubMed ID: 12400250
[TBL] [Abstract][Full Text] [Related]
7. Insulin-related metabolic changes during treatment with valproate in patients with epilepsy.
Pylvänen V; Pakarinen A; Knip M; Isojärvi J
Epilepsy Behav; 2006 May; 8(3):643-8. PubMed ID: 16600693
[TBL] [Abstract][Full Text] [Related]
8. Weight gain in children treated with valproate.
Sharpe C; Wolfson T; Trauner DA
J Child Neurol; 2009 Mar; 24(3):338-41. PubMed ID: 19258293
[TBL] [Abstract][Full Text] [Related]
9. Sodium valproate, hyperandrogenism and altered ovarian function in Indian women with epilepsy: a prospective study.
Prabhakar S; Sahota P; Kharbanda PS; Siali R; Jain V; Lal V; Khurana D
Epilepsia; 2007 Jul; 48(7):1371-7. PubMed ID: 17441994
[TBL] [Abstract][Full Text] [Related]
10. Impact on weight and height with the use of HAART in HIV-infected children.
Guillén S; Ramos JT; Resino R; Bellón JM; Muñoz MA
Pediatr Infect Dis J; 2007 Apr; 26(4):334-8. PubMed ID: 17414398
[TBL] [Abstract][Full Text] [Related]
11. Serum lipid changes during anticonvulsive treatment serum lipids in epileptic children.
Yilmaz E; Doşan Y; Gürgöze MK; Güngör S
Acta Neurol Belg; 2001 Dec; 101(4):217-20. PubMed ID: 11851028
[TBL] [Abstract][Full Text] [Related]
12. Effect of phenytoin and valproic acid therapy on serum lipid levels and liver function tests.
Dewan P; Aggarwal A; Faridi MM
Indian Pediatr; 2008 Oct; 45(10):855-8. PubMed ID: 18948659
[TBL] [Abstract][Full Text] [Related]
13. Growth and lipid metabolism in girls and young women with epilepsy during pubertal maturation.
Mikkonen K; Knip M; Pakarinen AJ; Lanning P; Isojärvi JI; Vainionpää LK
Epilepsia; 2005 Jul; 46(7):1114-20. PubMed ID: 16026564
[TBL] [Abstract][Full Text] [Related]
14. Effect of valproic acid treatment on body composition, leptin and the soluble leptin receptor in epileptic children.
Rauchenzauner M; Haberlandt E; Scholl-Bürgi S; Karall D; Schoenherr E; Tatarczyk T; Engl J; Laimer M; Luef G; Ebenbichler CF
Epilepsy Res; 2008 Aug; 80(2-3):142-9. PubMed ID: 18472247
[TBL] [Abstract][Full Text] [Related]
15. States of serum leptin and insulin in children with epilepsy: risk predictors of weight gain.
Hamed SA; Fida NM; Hamed EA
Eur J Paediatr Neurol; 2009 May; 13(3):261-8. PubMed ID: 18586538
[TBL] [Abstract][Full Text] [Related]
16. The metabolic syndrome in overweight epileptic patients treated with valproic acid.
Verrotti A; Manco R; Agostinelli S; Coppola G; Chiarelli F
Epilepsia; 2010 Feb; 51(2):268-73. PubMed ID: 19682024
[TBL] [Abstract][Full Text] [Related]
17. Determinants of weight gain in children from 7 to 10 years.
Valerio G; D'Amico O; Adinolfi M; Munciguerra A; D'Amico R; Franzese A
Nutr Metab Cardiovasc Dis; 2006 May; 16(4):272-8. PubMed ID: 16679219
[TBL] [Abstract][Full Text] [Related]
18. Contribution of early weight gain to childhood overweight and metabolic health: a longitudinal study (EarlyBird 36).
Gardner DS; Hosking J; Metcalf BS; Jeffery AN; Voss LD; Wilkin TJ
Pediatrics; 2009 Jan; 123(1):e67-73. PubMed ID: 19117849
[TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
20. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
